JCM, Vol. 14, Pages 8413: Epicardial Fat and Heart Failure in Type 2 Diabetes: Metabolism, Imaging and Novel Biomarkers—A Translational Perspective
JCM, Vol. 14, Pages 8413: Epicardial Fat and Heart Failure in Type 2 Diabetes: Metabolism, Imaging and Novel Biomarkers—A Translational Perspective Journal of Clinical Medicine doi: 10.3390/jcm14238413 Authors: Pedro Gil-Millan José Rives José Luis Sánchez-Quesada Antonio Pérez Heart failure (HF) is a major cardiovascular complication in people with type 2 diabetes (T2D), where heart failure […]
Thanksgiving foods to skip while taking ozempic or other weight-loss drugs, says dietitian
For individuals taking GLP‑1 medications such as Ozempic, Thanksgiving doesn’t have to be restrictive, but specific foods and beverages need caution. Dietitian Kylie Bensley recommends avoiding mac and cheese, candied yams, and heavy or cream-based alcoholic drinks because of their impact on blood sugar and digestion. Safer choices are protein packed foods, vegetables, light desserts […]
GLP-1 drugs may be associated with an increased risk of chronic cough, raising the need to study this mechanism and longitudinal cough dynamics objectively
submitted by /u/Cough_Geek [link] [comments]
Are Sexual Side Effects Emerging With GLP-1 Agonists?
GLP-1 receptor agonists affect sexual function differently across individuals and influencing libido and hormone levels in men and women during treatment. Medscape News Europe
Is Chronic Cough Another Side Effect of GLP-1 Drugs?
(MedPage Today) — GLP-1 receptor agonist use was associated with chronic cough regardless of a previous gastroesophageal reflux disease (GERD) diagnosis, a study of over 2 million people with type 2 diabetes suggested. Adults prescribed a GLP…
From blood sugar to brain relief: GLP-1 therapy slashes migraine frequency
Comments
Novo submits high-dose Wegovy for FDA approval using voucher
Novo Nordisk submitted a higher dose of its obesity drug Wegovy for FDA approval and is using a recently-won voucher to expedite the review. The company said Wednesday that it submitted …
Generic drug companies rework pricing to gain weight in India’s GLP-1 market as Novo Nordisk slashes Wegovy prices
Indian drugmakers are adjusting prices for weight-loss injections. Novo Nordisk has cut prices for its drug Wegovy. This move is prompting generic companies to lower their expected launch prices. Novo Nordisk is also preparing to launch Ozempic in India soon. This competition is expected to drive down prices in the GLP-1 segment.
Novo’s MFN prices to supersede IRA prices for Ozempic, Wegovy, CMS says
The new negotiated prices for Novo Nordisk’s GLP-1 drugs under the Inflation Reduction Act have raised questions about how they will impact the prices Novo agreed to under its separate “most favored nation” deal with …
Medicare negotiated lower prices for 15 drugs, including 71% off Ozempic and Wegovy
Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include Ozempic and also drugs to treat asthma, breast cancer and leukemia.